EUVIMEDEUVIMED entdecken
Open Access

Beyond plasma: defining the translation value of epithelial lining fluid exposure profiles for the treatment of pneumonia

Yakun Fu, Andrew J Fratoni, David P Nicolau iD

Journal of Antimicrobial Chemotherapy · 04.03.2026 · 81 (4)

DOI: 10.1093/jac/dkaf458 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Antimicrobial Chemotherapy, online erschienen am 04.03.2026. Verfasst von Yakun Fu und 2 weiteren Autor:innen. Beteiligte Einrichtung: Center for Anti-Infective Research and Development, Hartford Hospital, 80 Seymour Street, Hartford, CT 06102, USA. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Klebsiella pneumoniae, Plasma, Klebsiella Infections. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: CARB-X, Center for Anti-Infective Research and Development, U.S. Department of Health and Human Services.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Plasma pharmacokinetic/pharmacodynamic (PK/PD) targets are a surrogate of pulmonary exposures for pneumonia, despite potential differences in exposures. This study defined free plasma and pulmonary epithelial lining fluid (ELF) PK/PD targets for different antibiotics against Klebsiella pneumoniae (KP) in a preclinical pneumonia model, and assessed the predicted cfu/lung response of human exposures relative to MIC breakpoints.

Method

Secondary analyses were performed on previously published in vivo cfu/lung data generated using 17 KP after administration of different dosing regimens of meropenem, cefiderocol, levofloxacin and tobramycin. Efficacy was evaluated as change in log10 cfu/lung at 24 h. Emax models were fitted to composite cfu data, and plasma and ELF targets were calculated using the Hill equation. The average human plasma and ELF exposures achieved clinically relative to MIC breakpoints were overlaid on the Emax curve to predict corresponding cfu/lung efficacy.

Results

All Emax models had an R2 > 0.85. ELF targets differed from plasma targets and were generally lower (meropenem, cefiderocol and tobramycin), but higher for levofloxacin. Based on average human ELF exposures, the predicted cfu/lung responses of all four antibiotics were ≥1 log10 cfu/lung reduction at susceptible MICs, variable at intermediate MICs and limited at resistant MICs. Based on plasma targets, both meropenem and cefiderocol predicted cfu reduction at resistant breakpoints, whereas ELF exposures predicted net growth.

Conclusion

These data demonstrate the clinical translation of the pneumonia model relative to established breakpoints and emphasizes the potential limitations of relying solely on plasma exposure targets in predicting clinical efficacy for pneumonia.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Bacterial AgentsKlebsiella pneumoniaePlasmaKlebsiella InfectionsPneumonia, BacterialHumansMicrobial Sensitivity TestsCefiderocolAnimalsLevofloxacinLungCephalosporinsTobramycinMeropenemColony Count, Microbial

Substanzen

Anti-Bacterial AgentsCefiderocolLevofloxacinCephalosporinsTobramycinMeropenem

Autor:innen und Institutionen

  • Center for Anti-Infective Research and Development, Hartford Hospital, 80 Seymour Street, Hartford, CT 06102, USA.

ORCID-Profile: David P Nicolau

Förderung

  • CARB-X
  • Center for Anti-Infective Research and Development
  • U.S. Department of Health and Human Services
  • Administration for Strategic Preparedness and Response
  • Biomedical Advanced Research and Development Authority
  • Wellcome
  • Germany's Federal Ministry of Education and Research
  • UK Department of Health and Social Care

Zitieren

APA

Fu, Y., Fratoni, A. J., & Nicolau, D. P. (2026). Beyond plasma: defining the translation value of epithelial lining fluid exposure profiles for the treatment of pneumonia. Journal of Antimicrobial Chemotherapy, 81(4). https://doi.org/10.1093/jac/dkaf458

Vancouver

Fu Y, Fratoni AJ, Nicolau DP. Beyond plasma: defining the translation value of epithelial lining fluid exposure profiles for the treatment of pneumonia. Journal of Antimicrobial Chemotherapy. 2026;81(4). doi:10.1093/jac/dkaf458

BibTeX
@article{Fu2026,
  author = {Fu, Yakun and Fratoni, Andrew J and Nicolau, David P},
  title = {Beyond plasma: defining the translation value of epithelial lining fluid exposure profiles for the treatment of pneumonia},
  journal = {Journal of Antimicrobial Chemotherapy},
  year = {2026},
  volume = {81},
  number = {4},
  doi = {10.1093/jac/dkaf458}
}
Kostenlos starten →